David Larsen
Stock Analyst at BTIG
(2.69)
# 2,120
Out of 4,983 analysts
76
Total ratings
36.07%
Success rate
0.32%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Reiterates: Buy | $20 | $8.64 | +131.48% | 5 | Sep 9, 2025 | |
| HCAT Health Catalyst | Reiterates: Neutral | n/a | $2.88 | - | 4 | Sep 5, 2025 | |
| VEEV Veeva Systems | Maintains: Buy | $335 → $340 | $273.88 | +24.14% | 2 | Aug 28, 2025 | |
| SLP Simulations Plus | Maintains: Buy | $41 → $25 | $15.43 | +62.02% | 3 | Jul 7, 2025 | |
| CYRX Cryoport | Maintains: Buy | $13 → $10 | $8.99 | +11.23% | 3 | Jul 7, 2025 | |
| DOCS Doximity | Upgrades: Buy | $80 | $72.08 | +10.99% | 2 | Jun 2, 2025 | |
| PGNY Progyny | Upgrades: Buy | $28 | $21.77 | +28.62% | 4 | Mar 31, 2025 | |
| HIMS Hims & Hers Health | Initiates: Buy | $35 | $50.89 | -31.22% | 1 | Jan 7, 2025 | |
| HQY HealthEquity | Maintains: Buy | $110 → $130 | $91.54 | +42.01% | 4 | Nov 14, 2024 | |
| CCSI Consensus Cloud Solutions | Maintains: Buy | $30 → $31 | $28.28 | +9.62% | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $290 → $260 | $186.81 | +39.18% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $20 | $27.10 | -26.20% | 2 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $70 | $29.71 | +135.61% | 1 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $4.09 | +71.15% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $1.53 | +357.52% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $14 | $6.01 | +132.95% | 3 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.38 | - | 2 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $32.32 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $1.12 | - | 1 | Jun 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $22.32 | +56.81% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $7.87 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $6.53 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $148.37 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $693.45 | -76.93% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $68.39 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $73.48 | +15.68% | 3 | Feb 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $34 → $23 | $4.96 | +363.71% | 1 | Nov 2, 2017 |
Evolent Health
Sep 9, 2025
Reiterates: Buy
Price Target: $20
Current: $8.64
Upside: +131.48%
Health Catalyst
Sep 5, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.88
Upside: -
Veeva Systems
Aug 28, 2025
Maintains: Buy
Price Target: $335 → $340
Current: $273.88
Upside: +24.14%
Simulations Plus
Jul 7, 2025
Maintains: Buy
Price Target: $41 → $25
Current: $15.43
Upside: +62.02%
Cryoport
Jul 7, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $8.99
Upside: +11.23%
Doximity
Jun 2, 2025
Upgrades: Buy
Price Target: $80
Current: $72.08
Upside: +10.99%
Progyny
Mar 31, 2025
Upgrades: Buy
Price Target: $28
Current: $21.77
Upside: +28.62%
Hims & Hers Health
Jan 7, 2025
Initiates: Buy
Price Target: $35
Current: $50.89
Upside: -31.22%
HealthEquity
Nov 14, 2024
Maintains: Buy
Price Target: $110 → $130
Current: $91.54
Upside: +42.01%
Consensus Cloud Solutions
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $28.28
Upside: +9.62%
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $186.81
Upside: +39.18%
Oct 3, 2024
Maintains: Buy
Price Target: $15 → $20
Current: $27.10
Upside: -26.20%
Oct 3, 2024
Maintains: Buy
Price Target: $60 → $70
Current: $29.71
Upside: +135.61%
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $4.09
Upside: +71.15%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $1.53
Upside: +357.52%
Apr 23, 2024
Maintains: Buy
Price Target: $13 → $14
Current: $6.01
Upside: +132.95%
Apr 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $8.38
Upside: -
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $32.32
Upside: -
Jun 24, 2022
Initiates: Neutral
Price Target: n/a
Current: $1.12
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $22.32
Upside: +56.81%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $7.87
Upside: -
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $6.53
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $148.37
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $693.45
Upside: -76.93%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $68.39
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $73.48
Upside: +15.68%
Nov 2, 2017
Maintains: Market Perform
Price Target: $34 → $23
Current: $4.96
Upside: +363.71%